Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 129 entries
Sorted by: Best Match Show Resources per page
Q&A: Mina Bissell on tumors as organs.

Cancer discovery

Bissell M.
PMID: 23319753
Cancer Discov. 2013 Jan;3(1):7. doi: 10.1158/2159-8290.CD-ND2012-044.

No abstract available.

Cite
Bissell M. Q&A: Mina Bissell on tumors as organs. Cancer Discov. 2013;3(1):7doi: 10.1158/2159-8290.CD-ND2012-044.
Bissell, M. (2013). Q&A: Mina Bissell on tumors as organs. Cancer discovery, 3(1), 7. https://doi.org/10.1158/2159-8290.CD-ND2012-044
Bissell, Mina. "Q&A: Mina Bissell on tumors as organs." Cancer discovery vol. 3,1 (2013): 7. doi: https://doi.org/10.1158/2159-8290.CD-ND2012-044
Bissell M. Q&A: Mina Bissell on tumors as organs. Cancer Discov. 2013 Jan;3(1):7. doi: 10.1158/2159-8290.CD-ND2012-044. PMID: 23319753.
Copy Download .nbib Format: NLM
The role played by the microenvironment in site-specific metastasis.

Cancer letters

Klein-Goldberg A, Maman S, Witz IP.
PMID: 23988268
Cancer Lett. 2014 Sep 28;352(1):54-8. doi: 10.1016/j.canlet.2013.08.029. Epub 2013 Aug 27.

Cancer cells that disseminate to metastatic sites may progress to frank metastasis or persist as dormant micrometastasis. Significant progress has been made in defining the genetic and phenotypic cancer-cell-autonomous determinants of metastasis and in the understanding of the cross-talk...

Cite
Klein-Goldberg A, Maman S, Witz IP. The role played by the microenvironment in site-specific metastasis. Cancer Lett. 2013;352(1):54-8doi: 10.1016/j.canlet.2013.08.029.
Klein-Goldberg, A., Maman, S., & Witz, I. P. (2014). The role played by the microenvironment in site-specific metastasis. Cancer letters, 352(1), 54-8. https://doi.org/10.1016/j.canlet.2013.08.029
Klein-Goldberg, Anat, et al. "The role played by the microenvironment in site-specific metastasis." Cancer letters vol. 352,1 (2014): 54-8. doi: https://doi.org/10.1016/j.canlet.2013.08.029
Klein-Goldberg A, Maman S, Witz IP. The role played by the microenvironment in site-specific metastasis. Cancer Lett. 2014 Sep 28;352(1):54-8. doi: 10.1016/j.canlet.2013.08.029. Epub 2013 Aug 27. PMID: 23988268.
Copy Download .nbib Format: NLM
Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis.

Genome biology

Ma S, Ogino S, Parsana P, Nishihara R, Qian Z, Shen J, Mima K, Masugi Y, Cao Y, Nowak JA, Shima K, Hoshida Y, Giovannucci EL, Gala MK, Chan AT, Fuchs CS, Parmigiani G, Huttenhower C, Waldron L.
PMID: 30253799
Genome Biol. 2018 Sep 25;19(1):142. doi: 10.1186/s13059-018-1511-4.

BACKGROUND: Previous approaches to defining subtypes of colorectal carcinoma (CRC) and other cancers based on transcriptomes have assumed the existence of discrete subtypes. We analyze gene expression patterns of colorectal tumors from a large number of patients to test...

Cite
Ma S, Ogino S, Parsana P, et al. Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome Biol. 2018;19(1):142doi: 10.1186/s13059-018-1511-4.
Ma, S., Ogino, S., Parsana, P., Nishihara, R., Qian, Z., Shen, J., Mima, K., Masugi, Y., Cao, Y., Nowak, J. A., Shima, K., Hoshida, Y., Giovannucci, E. L., Gala, M. K., Chan, A. T., Fuchs, C. S., Parmigiani, G., Huttenhower, C., & Waldron, L. (2018). Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome biology, 19(1), 142. https://doi.org/10.1186/s13059-018-1511-4
Ma, Siyuan, et al. "Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis." Genome biology vol. 19,1 (2018): 142. doi: https://doi.org/10.1186/s13059-018-1511-4
Ma S, Ogino S, Parsana P, Nishihara R, Qian Z, Shen J, Mima K, Masugi Y, Cao Y, Nowak JA, Shima K, Hoshida Y, Giovannucci EL, Gala MK, Chan AT, Fuchs CS, Parmigiani G, Huttenhower C, Waldron L. Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome Biol. 2018 Sep 25;19(1):142. doi: 10.1186/s13059-018-1511-4. PMID: 30253799; PMCID: PMC6154428.
Copy Download .nbib Format: NLM
Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders.

Advances in experimental medicine and biology

Serpa J.
PMID: 32130691
Adv Exp Med Biol. 2020;1219:1-34. doi: 10.1007/978-3-030-34025-4_1.

The microenvironment depends and generates dependence on all the cells and structures that share the same niche, the biotope. The contemporaneous view of the tumor microenvironment (TME) agrees with this idea. The cells that make up the tumor, whether...

Cite
Serpa J. Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders. Adv Exp Med Biol. 2020;1219:1-34doi: 10.1007/978-3-030-34025-4_1.
Serpa, J. (2020). Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders. Advances in experimental medicine and biology, 12191-34. https://doi.org/10.1007/978-3-030-34025-4_1
Serpa, Jacinta. "Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders." Advances in experimental medicine and biology vol. 1219 (2020): 1-34. doi: https://doi.org/10.1007/978-3-030-34025-4_1
Serpa J. Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders. Adv Exp Med Biol. 2020;1219:1-34. doi: 10.1007/978-3-030-34025-4_1. PMID: 32130691.
Copy Download .nbib Format: NLM
Wnt Signaling: Paths for Cancer Progression.

Advances in experimental medicine and biology

Carreira-Barbosa F, Nunes SC.
PMID: 32130700
Adv Exp Med Biol. 2020;1219:189-202. doi: 10.1007/978-3-030-34025-4_10.

The Wnt signaling pathways are well known for having several pivotal roles during embryonic development. However, the same developmental signaling pathways also present key roles in cancer initiation and progression. In this chapter, several issues regarding the roles of...

Cite
Carreira-Barbosa F, Nunes SC. Wnt Signaling: Paths for Cancer Progression. Adv Exp Med Biol. 2020;1219:189-202doi: 10.1007/978-3-030-34025-4_10.
Carreira-Barbosa, F., & Nunes, S. C. (2020). Wnt Signaling: Paths for Cancer Progression. Advances in experimental medicine and biology, 1219189-202. https://doi.org/10.1007/978-3-030-34025-4_10
Carreira-Barbosa, Filipa, and Nunes, Sofia C. "Wnt Signaling: Paths for Cancer Progression." Advances in experimental medicine and biology vol. 1219 (2020): 189-202. doi: https://doi.org/10.1007/978-3-030-34025-4_10
Carreira-Barbosa F, Nunes SC. Wnt Signaling: Paths for Cancer Progression. Adv Exp Med Biol. 2020;1219:189-202. doi: 10.1007/978-3-030-34025-4_10. PMID: 32130700.
Copy Download .nbib Format: NLM
Cancer Evolution Constrained by the Immune Microenvironment.

Cell

McGranahan N, Swanton C.
PMID: 28841415
Cell. 2017 Aug 24;170(5):825-827. doi: 10.1016/j.cell.2017.08.012.

Tumor development is a Darwinian evolutionary process, involving the interplay between cancer subclones and the local immune microenvironment. These complex interactions are highlighted in this issue of Cell by the results from Jiménez-Sánchez et al. of a deep analysis...

Cite
McGranahan N, Swanton C. Cancer Evolution Constrained by the Immune Microenvironment. Cell. 2017;170(5):825-827doi: 10.1016/j.cell.2017.08.012.
McGranahan, N., & Swanton, C. (2017). Cancer Evolution Constrained by the Immune Microenvironment. Cell, 170(5), 825-827. https://doi.org/10.1016/j.cell.2017.08.012
McGranahan, Nicholas, and Swanton, Charles. "Cancer Evolution Constrained by the Immune Microenvironment." Cell vol. 170,5 (2017): 825-827. doi: https://doi.org/10.1016/j.cell.2017.08.012
McGranahan N, Swanton C. Cancer Evolution Constrained by the Immune Microenvironment. Cell. 2017 Aug 24;170(5):825-827. doi: 10.1016/j.cell.2017.08.012. PMID: 28841415.
Copy Download .nbib Format: NLM
Ketogenic diet in the treatment of cancer - Where do we stand?.

Molecular metabolism

Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B.
PMID: 31399389
Mol Metab. 2020 Mar;33:102-121. doi: 10.1016/j.molmet.2019.06.026. Epub 2019 Jul 27.

BACKGROUND: Cancer is one of the greatest public health challenges worldwide, and we still lack complementary approaches to significantly enhance the efficacy of standard anticancer therapies. The ketogenic diet, a high-fat, low-carbohydrate diet with adequate amounts of protein, appears...

Cite
Weber DD, Aminzadeh-Gohari S, Tulipan J, et al. Ketogenic diet in the treatment of cancer - Where do we stand?. Mol Metab. 2019;33:102-121doi: 10.1016/j.molmet.2019.06.026.
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer - Where do we stand?. Molecular metabolism, 33102-121. https://doi.org/10.1016/j.molmet.2019.06.026
Weber, Daniela D, et al. "Ketogenic diet in the treatment of cancer - Where do we stand?." Molecular metabolism vol. 33 (2020): 102-121. doi: https://doi.org/10.1016/j.molmet.2019.06.026
Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand?. Mol Metab. 2020 Mar;33:102-121. doi: 10.1016/j.molmet.2019.06.026. Epub 2019 Jul 27. PMID: 31399389; PMCID: PMC7056920.
Copy Download .nbib Format: NLM
Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.

Nature reviews. Genetics

Nam AS, Chaligne R, Landau DA.
PMID: 32807900
Nat Rev Genet. 2021 Jan;22(1):3-18. doi: 10.1038/s41576-020-0265-5. Epub 2020 Aug 17.

Cancer represents an evolutionary process through which growing malignant populations genetically diversify, leading to tumour progression, relapse and resistance to therapy. In addition to genetic diversity, the cell-to-cell variation that fuels evolutionary selection also manifests in cellular states, epigenetic...

Cite
Nam AS, Chaligne R, Landau DA. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. Nat Rev Genet. 2020;22(1):3-18doi: 10.1038/s41576-020-0265-5.
Nam, A. S., Chaligne, R., & Landau, D. A. (2021). Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. Nature reviews. Genetics, 22(1), 3-18. https://doi.org/10.1038/s41576-020-0265-5
Nam, Anna S, et al. "Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics." Nature reviews. Genetics vol. 22,1 (2021): 3-18. doi: https://doi.org/10.1038/s41576-020-0265-5
Nam AS, Chaligne R, Landau DA. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. Nat Rev Genet. 2021 Jan;22(1):3-18. doi: 10.1038/s41576-020-0265-5. Epub 2020 Aug 17. PMID: 32807900; PMCID: PMC8450921.
Copy Download .nbib Format: NLM
The origin of cancer.

Journal of internal medicine

Toftgård R.
PMID: 33769632
J Intern Med. 2021 May;289(5):601-603. doi: 10.1111/joim.13280. Epub 2021 Mar 26.

No abstract available.

Cite
Toftgård R. The origin of cancer. J Intern Med. 2021;289(5):601-603doi: 10.1111/joim.13280.
Toftgård, R. (2021). The origin of cancer. Journal of internal medicine, 289(5), 601-603. https://doi.org/10.1111/joim.13280
Toftgård, R. "The origin of cancer." Journal of internal medicine vol. 289,5 (2021): 601-603. doi: https://doi.org/10.1111/joim.13280
Toftgård R. The origin of cancer. J Intern Med. 2021 May;289(5):601-603. doi: 10.1111/joim.13280. Epub 2021 Mar 26. PMID: 33769632.
Copy Download .nbib Format: NLM
A TME-activated in situ nanogenerator for magnetic resonance/fluorescence/photoacoustic imaging.

Methods in enzymology

Xu S, Shi X, Chu C, Liu G.
PMID: 34353485
Methods Enzymol. 2021;657:145-156. doi: 10.1016/bs.mie.2021.06.029. Epub 2021 Jul 13.

With the rapid development of biomedical imaging, non-invasive imaging method particularly has been widely used in clinical diagnosis. Different imaging methods have their own advantages, such as higher resolution of optical imaging, deeper penetration of acoustic imaging, high resolution...

Cite
Xu S, Shi X, Chu C, et al. A TME-activated in situ nanogenerator for magnetic resonance/fluorescence/photoacoustic imaging. Methods Enzymol. 2021;657:145-156doi: 10.1016/bs.mie.2021.06.029.
Xu, S., Shi, X., Chu, C., & Liu, G. (2021). A TME-activated in situ nanogenerator for magnetic resonance/fluorescence/photoacoustic imaging. Methods in enzymology, 657145-156. https://doi.org/10.1016/bs.mie.2021.06.029
Xu, Shuyu, et al. "A TME-activated in situ nanogenerator for magnetic resonance/fluorescence/photoacoustic imaging." Methods in enzymology vol. 657 (2021): 145-156. doi: https://doi.org/10.1016/bs.mie.2021.06.029
Xu S, Shi X, Chu C, Liu G. A TME-activated in situ nanogenerator for magnetic resonance/fluorescence/photoacoustic imaging. Methods Enzymol. 2021;657:145-156. doi: 10.1016/bs.mie.2021.06.029. Epub 2021 Jul 13. PMID: 34353485.
Copy Download .nbib Format: NLM
Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment.

International journal of molecular sciences

Massey AE, Malik S, Sikander M, Doxtater KA, Tripathi MK, Khan S, Yallapu MM, Jaggi M, Chauhan SC, Hafeez BB.
PMID: 34067896
Int J Mol Sci. 2021 May 17;22(10). doi: 10.3390/ijms22105278.

Exosomes are nanoscale vesicles generated by cells for intercellular communication. Due to their composition, significant research has been conducted to transform these particles into specific delivery systems for various disease states. In this review, we discuss the common isolation...

Cite
Massey AE, Malik S, Sikander M, et al. Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment. Int J Mol Sci. 2021;22(10)doi: 10.3390/ijms22105278.
Massey, A. E., Malik, S., Sikander, M., Doxtater, K. A., Tripathi, M. K., Khan, S., Yallapu, M. M., Jaggi, M., Chauhan, S. C., & Hafeez, B. B. (2021). Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment. International journal of molecular sciences, 22(10), . https://doi.org/10.3390/ijms22105278
Massey, Andrew E, et al. "Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment." International journal of molecular sciences vol. 22,10 (2021). doi: https://doi.org/10.3390/ijms22105278
Massey AE, Malik S, Sikander M, Doxtater KA, Tripathi MK, Khan S, Yallapu MM, Jaggi M, Chauhan SC, Hafeez BB. Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment. Int J Mol Sci. 2021 May 17;22(10). doi: 10.3390/ijms22105278. PMID: 34067896; PMCID: PMC8156384.
Copy Download .nbib Format: NLM
Microbe-based management for colorectal cancer.

Chinese medical journal

Gao ZY, Cui Z, Yan YQ, Ning LJ, Wang ZH, Hong J.
PMID: 34855639
Chin Med J (Engl). 2021 Dec 01;134(24):2922-2930. doi: 10.1097/CM9.0000000000001887.

ABSTRACT: Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential...

Cite
Gao ZY, Cui Z, Yan YQ, et al. Microbe-based management for colorectal cancer. Chin Med J (Engl). 2021;134(24):2922-2930doi: 10.1097/CM9.0000000000001887.
Gao, Z. Y., Cui, Z., Yan, Y. Q., Ning, L. J., Wang, Z. H., & Hong, J. (2021). Microbe-based management for colorectal cancer. Chinese medical journal, 134(24), 2922-2930. https://doi.org/10.1097/CM9.0000000000001887
Gao, Zi-Yun, et al. "Microbe-based management for colorectal cancer." Chinese medical journal vol. 134,24 (2021): 2922-2930. doi: https://doi.org/10.1097/CM9.0000000000001887
Gao ZY, Cui Z, Yan YQ, Ning LJ, Wang ZH, Hong J. Microbe-based management for colorectal cancer. Chin Med J (Engl). 2021 Dec 01;134(24):2922-2930. doi: 10.1097/CM9.0000000000001887. PMID: 34855639.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 129 entries